Appendage closure is an alternative to anticoagulation therapy - Rebuttal CON

18 March 2018 (15:19 - 15:24)

Organised by:

Video

Sign in for access options

11 More presentations in this session

Presentation thumbnail

Opening question

Presentation thumbnail

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism- PRO

Doctor S. Themistoclakis (Venice, IT)

Presentation thumbnail

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - CON

Professor T. Potpara (Belgrade, RS)

Presentation thumbnail

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal PRO

Presentation thumbnail

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal CON

Access the full session

Session thumbnail

Tough decisions in anticoagulation in atrial fibrillation

The Event

EHRA 2018

18 March 2018 15:19 CET

You may be interested in

Congress Presentation

Left atrial appendage closure: who should get it and how to manage patients medically before, during and after?

27 August 2023

Congress Presentation

Non valvular atrial fibrillation, contraindication to anticoagulation or antiplatelet therapy and heart team approach: a single centre experience

2 September 2019

Congress Presentation

Left atrial appendage closure in atrial fibrillation: gaps in knowledge

1 September 2025

Congress Session

Antithrombotic therapy for critically ill patients: focusing on anticoagulants

26 March 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources